A molecular mechanism for the effect of lithium on development.
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms. How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase). We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium. Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3 beta (GSK-3 beta), which regulates cell fate determination in diverse organisms including Dictyostelium, Drosophila, and Xenopus. Lithium potently inhibits GSK-3 beta activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases. In support of this hypothesis, lithium treatment phenocopies loss of GSK-3 beta function in Xenopus and Dictyostelium. These observations help explain the effect of lithium on cell-fate determination and could provide insights into the pathogenesis and treatment of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., & Irvine, R. F. (1983) · Biochemical Journal · doi:10.1042/bj2120473 · Cited by 1,954
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Hallcher, L. M., & Sherman, W. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70391-3 · Cited by 1,101
Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4
Stark, K., Vainio, S., Vassileva, G., & McMahon, A. P. (1994) · Nature · doi:10.1038/372679a0 · Cited by 1,071
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,014
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15
Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K. T., & Varmus, H. (1984) · Nature · doi:10.1038/307131a0 · Cited by 612
McMahon, A. P., & Moon, R. T. (1989) · Cell · doi:10.1016/0092-8674(89)90506-0 · Cited by 529
Cited by
Items 201–300 of 302
Lazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230
Sox9 Inhibits Wnt Signaling by Promoting β-Catenin Phosphorylation in the Nucleus
Topol, L., Chen, W., Song, H., Day, T. F., & Yang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808048200 · Cited by 230
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225
Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling
Yasumoto, K.-I. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2703 · Cited by 228
Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225
“GSK3 has been suspected of contributing to bipolar disorder since the discovery that lithium, an effective mood stabilizer used therapeutically for bipolar disorder, is a selective inhibitor of GSK3 (Klein and Melton, 1996; Stambolic et al, 1996).”
BackgroundEngel, T., Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04139.x · Cited by 223
Effects of Lithium on Inflammation
Nassar, A., & Azab, A. N. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500038f · Cited by 219
Leng, Y., Liang, M.-H., Ren, M., Marinova, Z., Leeds, P., & Chuang, D.-M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5467-07.2008 · Cited by 214
“Lithium is known to directly inhibit glycogen synthase kinase-3 (GSK-3) activity (Klein and Melton, 1996; Stambolic et al., 1996).”
BackgroundYildiz, A., Guleryuz, S., Ankerst, D. P., Öngür, D., & Renshaw, P. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.43 · Cited by 213
“of episodes/subject, median (range)b Total 4 (1-42) 3 (1-41) .”
Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons
Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., & Inestrosa, N. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.028 · Cited by 213
Jirmanova, L., Afanassieff, M., Gobert-Gosse, S., Markossian, S., & Savatier, P. (2002) · Oncogene · doi:10.1038/sj.onc.1205728 · Cited by 212
“Immune complexes bound to protein A-sepharose were washed twice in phosphate buffer saline (PBS) pH 7.4, 1% NP40, 200 mM Na2VO4, twice in 0.5 M LiCl, 0.1 M Tris –HCl pH 7.4, and twice in 10 mM Tris –HCl pH 7.4, 100 mM NaCl, 1 mM EDTA, 200 mM Na2VO4.”
BackgroundInfluentialLithium and bipolar mood disorder: the inositol-depletion hypothesis revisited
Harwood, A. J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001618 · Cited by 209
Cellular Circadian Clocks in Mood Disorders
McCarthy, M. J., & Welsh, D. K. (2012) · Journal of Biological Rhythms · doi:10.1177/0748730412456367 · Cited by 203
“Lithium inhibits GSK3β (Klein and Melton, 1996), which phosphorylates the clock components BMAL1 (Sahar et al., 2010), CRY2 (Harada et al., 2005), PER2 (Iitaka et al., 2005), and REV-ERBα (Yin, 2006).”
BackgroundPharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans
McColl, G., Killilea, D. W., Hubbard, A. E., Vantipalli, M. C., Melov, S., & Lithgow, G. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705028200 · Cited by 202
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Carter, L., Johnson, K., & Henry, R. R. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2190 · Cited by 198
Magnetic field effects in biology from the perspective of the radical pair mechanism
Zadeh-Haghighi, H., & Simon, C. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0325 · Cited by 197
Schepsky, A., Bruser, K., Gunnarsson, G. J., Goodall, J., Hallsson, J. H., Goding, C. R., Steingrimsson, E., & Hecht, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02299-05 · Cited by 197
“However, if transfected cells were stimulated with LiCl, which inhibits GSK-3 and thereby mimics Wnt signaling (26), -catenin was withdrawn from the cell membrane and accumulated mainly in the nucleus (Fig.”
BackgroundXing, B., Li, Y.-C., & Gao, W.-J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.005 · Cited by 196
Benedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195
Wnt Signaling in the Vertebrate Central Nervous System: From Axon Guidance to Synaptic Function
Salinas, P. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008003 · Cited by 193
A Conserved Docking Motif for CK1 Binding Controls the Nuclear Localization of NFAT1
Okamura, H., Garcia-Rodriguez, C., Martinson, H., Qin, J., Virshup, D. M., & Rao, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4184-4195.2004 · Cited by 188
“GSK3 activities, GST(1-415) was first primed with PKA as described above and”
BackgroundMethodInfluentialZhang, W., Zhao, Y., Tong, C., Wang, G., Wang, B., Jia, J., & Jiang, J. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.01.001 · Cited by 187
Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184
BSK s are partially redundant positive regulators of brassinosteroid signaling in Arabidopsis
Sreeramulu, S., Mostizky, Y., Sunitha, S., Shani, E., Nahum, H., Salomon, D., Hayun, L. B., Gruetter, C., Rauh, D., Ori, N., et al. (2013) · The Plant Journal · doi:10.1111/tpj.12175 · Cited by 181
“To further confirm the specificity of BSK phosphorylation by BIN2, we performed kinase assays in the presence of lithium, an inhibitor of GSK3-like kinase (Klein and Melton, 1996; Zhao et al., 2002).”
MethodWnt Signaling in Vertebrate Axis Specification
Hikasa, H., & Sokol, S. Y. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007955 · Cited by 180
Nucleocytoplasmic Shuttling Factors Including Ran and CRM1 Mediate Nuclear Export of NFAT In Vitro
Kehlenbach, R. H., Dickmanns, A., & Gerace, L. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.863 · Cited by 180
“In contrast, the nuclear extract had only a minor stimulatory effect on protein import into the nucleus as compared with cytosol (from 14 units at 08C, to 22.6 and 100 Kehlenbach et al. Shuttling Factors in Nuclear Export 869 units at 308C for the nuclear extract and cytosol, respectively).”
BackgroundInfluentialLong-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres
Martinsson, L., Wei, Y., Xu, D., Melas, P. A., Mathé, A. A., Schalling, M., Lavebratt, C., & Backlund, L. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.37 · Cited by 179
“Lithium inhibits GSK-3b directly and reversibly, by regulating its transcription and by competing with Mg2þ and thereby disrupting the catalytic function of GSK-3b.39 Lithium also indirectly regulates GSK-3b activity by inducing various kinases and phosphatases, such as PI3K, PP2A, PKC and Akt, controlling phosphoryla…”
BackgroundInfluentialCalcium signaling in vertebrate embryonic patterning and morphogenesis
Slusarski, D. C., & Pelegri, F. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.04.043 · Cited by 178
“Subsequent findings indicated that another endogenous target of lithium is the β-catenin degradation complex component GSK-3, which when inhibited promotes dorsal axis induction (Klein and Melton, 1996; Stambolic et al., 1996).”
BackgroundGSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177
“Lithium is selective for GSK-3α and GSK-3β and does not inhibit other protein kinases tested in vitro and in vivo, including casein kinase II, protein kinase A and C, MAPK, and CDK5 [121, 126].”
BackgroundKing, T. D., Bijur, G. N., & Jope, R. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03005-0 · Cited by 177
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176
“It has been shown that lithium acts directly on GSK3 ( Klein and Melton, 1996 ), whereas valproate activates the Erk cascade in SH-SY5Y cells (Yuan et al., 2001).”
BackgroundGlycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 176
“The discovery that lithium directly inhibits GSK3 raised the possibility that this action contributes to the mood stabilizing action of lithium in bipolar disorder (Klein and Melton, 1996; Stambolic et al., 1996).”
The Wnt Signaling Pathway in Bipolar Disorder
Gould, T. D., & Manji, H. K. (2002) · The Neuroscientist · doi:10.1177/107385802237176 · Cited by 174
Marmol, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.012 · Cited by 174
“Another possible target of lithium action was identified by Klein and Melton (1996) when they demonstrated that lithium at therapeutic concentrations inhibited glycogen synthase kinase 3 (GSK-3).”
McCarthy, M. J., Nievergelt, C. M., Kelsoe, J. R., & Welsh, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032091 · Cited by 172
“Glycogen synthase kinase 3b (GSK3b) is inhibited by lithium [10], and has been implicated in both lithium’s effect on circadian rhythms [11,12], and its therapeutic action in BD [13].”
BackgroundPhosphorylation by NLK inhibits YAP ‐14‐3‐3‐interactions and induces its nuclear localization
Moon, S., Kim, W., Kim, S., Kim, Y., Song, Y., Bilousov, O., Kim, J., Lee, T., Cha, B., Kim, M., et al. (2017) · EMBO reports · doi:10.15252/embr.201642683 · Cited by 172
“Next, we used lithium chloride (LiCl), previously used as an inhibitor of NLK and GSK3b activities [23,24], to further test whether NLK has a negative effect on YAP phosphorylation at Ser127.”
Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
Balaraman, Y., Limaye, A. R., Levey, A. I., & Srinivasan, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5597-y · Cited by 167
Trivedi, N., Marsh, P., Goold, R. G., Wood-Kaczmar, A., & Gordon-Weeks, P. R. (2005) · Journal of Cell Science · doi:10.1242/jcs.01697 · Cited by 166
“binding of both antibodies was considerably reduced when lithium, a GSK-3 inhibitor (Klein and Melton, 1996; Stambolic et al., 1996), was included in the kinase assay buffer (Fig.”
InfluentialNovel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
Waaler, J., Machon, O., von Kries, J. P., Wilson, S. R., Lundenes, E., Wedlich, D., Gradl, D., Paulsen, J. E., Machonova, O., Dembinski, J. L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1282 · Cited by 165
“Downstream of the receptor level, the activity of GSK-3b can be inhibited by LiCl, resulting in inefficient phosphorylation of b-catenin and its subsequent degradation that ultimately leads to the activation of Wnt target genes (28, 29).”
BackgroundGao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
“Lithium is a type of selective GSK3 inhibitor, noncompetitive with ATP and the protein substrates to be phosphorylated (Klein and Melton , 1996 ; Avila and Hern á ndez, 2007 ).”
BackgroundPacheco-Pinedo, E. C., Durham, A. C., Stewart, K. M., Goss, A. M., Lu, M. M., DeMayo, F. J., & Morrisey, E. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44871 · Cited by 164
Small molecule enhancers of autophagy for neurodegenerative diseases
Sarkar, S., & Rubinsztein, D. C. (2008) · Molecular BioSystems · doi:10.1039/b804606a · Cited by 163
Antero-posterior tissue polarity links mesoderm convergent extension to axial patterning
Ninomiya, H., Elinson, R. P., & Winklbauer, R. (2004) · Nature · doi:10.1038/nature02620 · Cited by 163
“In our system, uniform exposure of dissociated cap cells, pretreated with LiC”
MethodWnts in adult brain: from synaptic plasticity to cognitive deficiencies
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00224 · Cited by 162
Mansour, H. A., Talkowski, M. E., Wood, J., Chowdari, K. V., McClain, L., Prasad, K., Montrose, D., Fagiolini, A., Friedman, E. S., Allen, M. H., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00756.x · Cited by 161
Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Beaulieu, J.-M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 160
“However, these studies were all conducted before the discovery of the effect of lithium on GSK3 (Klein and Melton, 1996; Stambolic et al., 1996), and the actions of lithium in these experimental systems were generally attributed to other mechanisms including changes in dopamine release or dopamine…”
BackgroundGSK-3 β at the Intersection of Neuronal Plasticity and Neurodegeneration
Jaworski, T., Banach-Kasper, E., & Gralec, K. (2019) · Neural Plasticity · doi:10.1155/2019/4209475 · Cited by 159
“For example, removal of GSK-3α and GSK-3β in cortical excitatory neurons leads to the failure of radial migration in the cortex [39].”
BackgroundInfluentialRansick, A., Rast, J. P., Minokawa, T., Calestani, C., & Davidson, E. H. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0607 · Cited by 152
Lithium: the pharmacodynamic actions of the amazing ion
Brown, K. M., & Tracy, D. K. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312471963 · Cited by 140
“Direct and indirect inhibition of GSK3 by lithium In 1996, two independent studies demonstrated lithium’s effects as a direct inhibitor of GSK3 in vitro and in cells [Klein and Melton, 1996; Stambolic et al. 1996].”
BackgroundInfluentialMin, W. W., Yuskaitis, C. J., Yan, Q., Sikorski, C., Chen, S., Jope, R. S., & Bauchwitz, R. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.017 · Cited by 146
β-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina
Meyers, J. R., Hu, L., Moses, A., Kaboli, K., Papandrea, A., & Raymond, P. A. (2012) · Neural Development · doi:10.1186/1749-8104-7-30 · Cited by 144
Hartigan, J. A., & Johnson, G. V. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21395 · Cited by 141
Röttinger, E., Dahlin, P., & Martindale, M. Q. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003164 · Cited by 140
“Nonetheless, all four components are broadly used in a variety of animals and generally considered universal canonical Wnt activators [59,72,74,105,108,109].”
BackgroundMcCarthy, M. J., Wei, H., Marnoy, Z., Darvish, R. M., McPhie, D. L., Cohen, B. M., & Welsh, D. K. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.90 · Cited by 137
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
O’Donnell, K. C., & Gould, T. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.002 · Cited by 137
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Mood disorders in the elderly: prevalence, functional impact, and management challenges
Forlenza, O. V., Valiengo, L., & Stella, F. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s94643 · Cited by 129
“…be attributed to the fact that lithium inhibits both the expression 76 and activity 77 of the enzyme glycogen synthase kinase-3 β , 71 as well as the inhibition of the overproduction of A β and the hyperphosphorylation of tau protein, 78 all directly involved in the neurodegenerative process in AD.”
Diniz, B., Machado-Vieira, R., & Forlenza (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s33086 · Cited by 128
“By dislocating Mg2+ from the enzyme catalytic core, lithium directly inhibits the enzyme activity.(8,9) In addition, lithium can also inhibit GSK-3β activity by inducing the phosphorylation of the serine-9 residue, leading to conformational changes and inactivation.”
ASsociation of gsk3β polymorphisms with brain structural changes in major depressive disorder
Inkster, B., Nichols, T. E., Saemann, P. G., Auer, D. P., Holsboer, F., Muglia, P., & Matthews, P. M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.70 · Cited by 127
The circadian system of patients with bipolar disorder differs in episodes of mania and depression
Nováková, M., Praško, J., Látalová, K., Sládek, M., & Sumová, A. (2015) · Bipolar Disorders · doi:10.1111/bdi.12270 · Cited by 123
Eom, T.-Y., & Jope, R. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.015 · Cited by 115
“Hyperactive GSK3 may contribute to mood disorders and schizophrenia (34) and GSK3 is inhibited by neurotrophins and by therapeutic drugs used in these diseases, including lithium (35,36), the classical mood stabilizer used to treat bipolar disorder (37), antidepressants (38), and antipsychotics (39-42).”
BackgroundAssessment of circadian function in fibroblasts of patients with bipolar disorder
Yang, S., Van Dongen, H. P. A., Wang, K., Berrettini, W., & Bućan, M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.10 · Cited by 113
Nielsen, J., Hoffert, J. D., Knepper, M. A., Agre, P., Nielsen, S., & Fenton, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800001105 · Cited by 109
Henriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108
“Finally, lithium ions, a noncompetitive and relatively nonselective inhibitor of GSK-3 with a Ki in the millimolar range (8, 16, 18, 32), can enhance both insulin-independent and insulindependent glucose transport in skeletal muscle from insulin-sensitive rats (34).”
BackgroundLeroy, K., Ando, K., Héraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J.-P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1276 · Cited by 103
“Lithium is a known inhibitor of GSK-3 β [11,12] and has been found to decrease tau phosphorylation in cultured neurons [13–15]and in rat brain [14].”
Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100
Lithium- and Valproate-Induced Alterations in Circadian Locomotor Behavior in Drosophila
Dokucu, M. E., Yu, L., & Taghert, P. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300764 · Cited by 96
“Although GSK-3b inhibition by lithium was first reported in an early developmental context in Xenopus and Drosophila (Klein and Melton, 1996; Stambolic et al, 1996; Hedgepeth et al, 1997), the body of evidence is increasing that this may be valid also in the mammalian central nervous system (CNS)…”
Wnt/β-Catenin Signaling in Alzheimer’s Disease
Ferrari, G., Avila, M., Medina, M., Perez-Palma, E., Bustos, B., & Alarcon, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223113900 · Cited by 95
Gerhard, T., Devanand, D. P., Huang, C., Crystal, S., & Olfson, M. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.154047 · Cited by 94
Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits
Beurel, E., & Jope, R. S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.129 · Cited by 92
Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells
Beurel, E., Yeh, W.-I., Michalek, S. M., Harrington, L. E., & Jope, R. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003511 · Cited by 86
GSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84
“The discovery that GSK3β is a direct target of lithium action [63] has raised the possibility that lithium exerts its effects through the odulating activity of the kinase.”
BackgroundNumata, S., Ishii, K., Tajima, A., Iga, J.-I., Kinoshita, M., Watanabe, S., Umehara, H., Fuchikami, M., Okada, S., Boku, S., et al. (2015) · Epigenetics · doi:10.1080/15592294.2014.1003743 · Cited by 79
“Treatment with the antidepressants fluoxetine and imipramine, as well as lithium, increased the level of phosphorSer9-GSK3B in mouse brain.(20,32) Furthermore, growing evidence indicated that BDNF also plays an important role in the pathophysiology of MDD,(33) and the phosphorylation of GSK3B mediated by BDNF/PI3K/Akt…”
BackgroundYuskaitis, C. J., Beurel, E., & Jope, R. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.015 · Cited by 79
Beurel, E., Grieco, S. F., Amadei, C., Downey, K., & Jope, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12436 · Cited by 76
Morgan-Smith, M., Wu, Y., Zhu, X., Pringle, J., & Snider, W. D. (2014) · eLife · doi:10.7554/elife.02663 · Cited by 76
Kapfhamer, D., Berger, K. H., Hopf, F. W., Seif, T., Kharazia, V., Bonci, A., & Heberlein, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1292-10.2010 · Cited by 71
“…2A (PP2A) and protein kinase B (also called AKT) (Cross et al., 1995; Ivaska et al., 2002; Lin et al., 2007); GSK3 is also a direct target of inhibition by lithium (Klein and Melton, 1996), one of the most widely prescribed drugs for the treatment of mood disorders (Quiroz et al., 2004).”
BackgroundNemo-like kinase, a multifaceted cell signaling regulator
Ishitani, T., & Ishitani, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.017 · Cited by 71
Reverse translational strategies for developing animal models of bipolar disorder
Malkesman, O., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001628 · Cited by 70
“Although the mechanisms of its therapeutic effect remain unknown, lithium was found to selectively inhibit a limited number of enzymes, including GSK-3 (Gould et al., 2004a; Klein and Melton, 1996).”
BackgroundLüdtke, T. H., Rudat, C., Wojahn, I., Weiss, A.-C., Kleppa, M.-J., Kurz, J., Farin, H. F., Moon, A., Christoffels, V. M., & Kispert, A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.08.007 · Cited by 69
Lewerenz, J., Baxter, P., Kassubek, R., Albrecht, P., Van Liefferinge, J., Westhoff, M.-A., Halatsch, M.-E., Karpel-Massler, G., Meakin, P. J., Hayes, J. D., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5455 · Cited by 66
“Indeed, 20 mM lithium chloride (LiCl), a GSK-3b inhibitor (19, 33), strongly induced eIF2a phosphorylation, ATF4 protein expression (Fig.”
BackgroundTsai, S.-J., Liou, Y.-J., Hong, C.-J., Yu, Y. W.-Y., & Chen, T.-J. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500486 · Cited by 66
Resende, W. R., Valvassori, S. S., Réus, G. Z., Varela, R. B., Arent, C. O., Ribeiro, K. F., Bavaresco, D. V., Andersen, M. L., Zugno, A. I., & Quevedo, J. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32836546fc · Cited by 65
“, 1982; Berridge and Irvine, 1989), arising from the observation that Li inhibits glycogen synthase kinase-3b (GSK-3b) at a close-totherapeutic concentration (Klein and Melton, 1996).”
BackgroundWhat sponges can tell us about the evolution of developmental processes
Adamska, M., Degnan, B. M., Green, K., & Zwafink, C. (2011) · Zoology · doi:10.1016/j.zool.2010.10.003 · Cited by 65
Glycogen Synthase Kinase 3β as a Likely Target for the Action of Lithium on Circadian Clocks
Padiath, Q. S., Paranjpe, D., Jain, S., & Sharma, V. K. (2004) · Chronobiology International · doi:10.1081/cbi-120027981 · Cited by 64
Aiston, S., Coghlan, M. P., & Agius, L. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03648.x · Cited by 62
Genetical genomics of behavior: a novel chicken genomic model for anxiety behavior
Johnsson, M., Williams, M. J., Jensen, P., & Wright, D. (2016) · Genetics · doi:10.1534/genetics.115.179010 · Cited by 62
“…several examples of other serine/threonine kinases affecting behavior, specifically learning and anxiety in Drosophila (Choi et al. 1991) andmice (Silva et al. 1992) (Hodge et al. 2002), with links to bipolar disorder (Klein and Melton 1996) and depression (Gould et al. 2004; O’Brien et al. 2004).”
BackgroundBiphasic regulation of glutamine consumption by WNT during osteoblast differentiation
Shen, L., Sharma, D., Yu, Y., Long, F., & Karner, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.251645 · Cited by 61
Costi, S., Soleimani, L., Glasgow, A., Brallier, J., Spivack, J., Schwartz, J., Levitch, C. F., Richards, S., Hoch, M., Stade, E. C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0365-0 · Cited by 56
Knockout mice in understanding the mechanism of action of lithium
Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371121 · Cited by 50
liu, Z., Guo, H., Cao, X., Cheng, C., Yang, C., Xu, C., Zhang, A., Sun, N., Li, X., & Zhang, K. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.05.010 · Cited by 50
Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, J., Rosenfelt, C., Gertner, M. J., Campbell, S. R., Emerson, D., Hinchey, P., Kollaros, M., et al. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00136 · Cited by 46
“In mouse studies this has been found, at least in part, to be secondary to the effects of lithium inhibiting GSK-3β activity (Klein and Melton, 1996; Mines et al., 2010, 2013; Yuskaitis et al., 2010).”
BackgroundNemo‐like kinase is involved in NGF‐induced neurite outgrowth via phosphorylating MAP1B and paxillin
Ishitani, T., Ishitani, S., Matsumoto, K., & Itoh, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06400.x · Cited by 46
Kinetics of Wnt-driven β-catenin stabilization revealed by quantitative and temporal imaging
Hannoush, R. N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003498 · Cited by 42
Argenton, F., Giudici, S., Deflorian, G., Cimbro, S., Cotelli, F., & Beltrame, M. (2004) · Mechanisms of Development · doi:10.1016/j.mod.2004.01.001 · Cited by 41
Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment
Chetcuti, A., Adams, L. J., Mitchell, P. B., & Schofield, P. R. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3282fb0051 · Cited by 41
Tan, H., Young, L. T., Shao, L., Che, Y., Honer, W. G., & Wang, J.-F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001416 · Cited by 40
Hudson, R., Green, M., Wright, D. J., Renard, J., Jobson, C. E. L., Jung, T., Rushlow, W., & Laviolette, S. R. (2021) · Addiction Biology · doi:10.1111/adb.12891 · Cited by 23
Liu, S., Sun, N., Xu, Y., Yang, C., Ren, Y., Liu, Z., Cao, X., Sun, Y., Xu, Q., Zhang, K., et al. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0227 · Cited by 21
“Lithium, a mood stabilizer that enhances the action of antidepressants, was found to inhibit GSK3b in vitro, in the mouse brain (Klein and Melton, 1996; Stambolic et al., 1996) and in human peripheral blood mononuclear cells (Li et al., 2007).”
BackgroundMizutani, R., Yamauchi, J., Kusakawa, S., Nakamura, K., Sanbe, A., Torii, T., Miyamoto, Y., & Tanoue, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.06.005 · Cited by 21
Metadata
- Authors
- Klein, P. S., & Melton, D. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-08-06
- Volume
- 93
- Issue
- 16
- Pages
- 8455-8459
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2051788298
- Cited by
- 2,301
- References
- 37
- FWCI
- 15.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.